Neptune Wellness Solutions Inc 's ability to collect accounts receivable sequentially worsen to 6.48, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Neptune Wellness Solutions Inc 's Accounts Receivable average collection period in the Dec 31 2023 quarter, has increased to 56 days, from 42 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 113 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 527 to 1222.

What is Receivable Turnover Ratio?
What is Neptune Wellness Solutions Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEPT Receivables Turnover Ratio	(Dec 31 2023) III. Quarter	(Sep 30 2023) II. Quarter	(Jun 30 2023) I. Quarter	(Mar 31 2023) IV. Quarter	(Dec 31 2022) III. Quarter
Y / Y Receivable Change	-	-	-	-35.7 %	-
Y / Y Revenue Change	-37.75 %	-27.09 %	-34.69 %	5.34 %	-16.76 %
Receivable Turnover Ratio (TTM)	6.48	8.64	12.01	13.45	8.55
NEPT's Total Ranking	# 1222	# 527	# 1004	# 1014	# 768
Accounts Receivable average collection period days	56	42	30	27	43
Seq. Receivable Change	-15.1 %	-	-	-	-
Seq. Revenue Change	-13.05 %	-17.76 %	-12.51 %	-0.5 %	1.85 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 46
Healthcare Sector	# 114
Overall Market	# 1222

Receivable Turnover Ratio Statistics
High	Average	Low
37.92	18.07	7.72
(Mar 31 2023)		(Mar 31 2022)

NEPT Company Profile • Back to NEPT Efficiency Comparisons • Compare NEPT Receivables Turnover Ratio to its Competitors

Financial Statements
Neptune Wellness Solutions Inc 's Accounts Receivable	$ 4 Millions	Visit NEPT's Balance sheet
Neptune Wellness Solutions Inc 's Sales TTM	$ 39 Millions	Visit NEPT's Income Statement
Sources of NEPT's Revenues		Visit NEPT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NEPT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NEPT's Growth Rates	NEPT's Roa	NEPT's Inventory Turnover Ratio	NEPT's Dividend Comparisons
NEPT's Profitability Ratios	NEPT's Roi	NEPT's Asset Turnover Ratio	NEPT's Dividend Growth
NEPT's Valuation Ratios	NEPT's Roe	NEPT's Financial Strength Ratios	NEPT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Onemednet Corporation	27.36	$ 1.040 Millions	$ 0.038 Millions
Zomedica Corp	26.82	$ 24.318 Millions	$ 0.907 Millions
Scorpius Holdings inc	26.72	$ 6.995 Millions	$ 0.262 Millions
National Vision Holdings Inc	26.38	$ 2,126.468 Millions	$ 80.611 Millions
Inmed Pharmaceuticals Inc	25.61	$ 5.487 Millions	$ 0.214 Millions
Orchestra Biomed Holdings Inc	25.56	$ 2.760 Millions	$ 0.108 Millions
Cv Sciences Inc	25.51	$ 15.085 Millions	$ 0.591 Millions
Anika Therapeutics Inc	25.20	$ 166.088 Millions	$ 6.590 Millions
Clearside Biomedical Inc	25.18	$ 8.226 Millions	$ 0.327 Millions
Cano Health Inc	24.48	$ 3,137.757 Millions	$ 128.172 Millions
Aquestive Therapeutics Inc	23.89	$ 50.583 Millions	$ 2.118 Millions
Innovage Holding Corp	22.69	$ 720.796 Millions	$ 31.768 Millions
Innoviva Inc	22.53	$ 315.267 Millions	$ 13.993 Millions
Lineage Cell Therapeutics Inc	22.09	$ 8.945 Millions	$ 0.405 Millions
Gyre Therapeutics Inc	22.08	$ 113.450 Millions	$ 5.138 Millions
Jrsis Health Care Corp	21.63	$ 3.939 Millions	$ 0.182 Millions
Agenus Inc	21.11	$ 156.314 Millions	$ 7.406 Millions
Kymera Therapeutics Inc	20.96	$ 78.592 Millions	$ 3.750 Millions
Vystar Corporation	20.75	$ 0.526 Millions	$ 0.025 Millions
Editas Medicine Inc	20.64	$ 78.123 Millions	$ 3.784 Millions
Cue Health Inc	20.01	$ 70.936 Millions	$ 3.545 Millions
Arvinas Inc	19.87	$ 78.500 Millions	$ 3.950 Millions
Rosecliff Acquisition Corp I	19.74	$ 18.056 Millions	$ 0.915 Millions
Kiniksa Pharmaceuticals International Plc	19.17	$ 270.259 Millions	$ 14.095 Millions
American Oncology Network Inc	18.94	$ 1,279.185 Millions	$ 67.548 Millions
U S Physical Therapy Inc	18.56	$ 487.150 Millions	$ 26.251 Millions
Marizyme Inc	18.31	$ 0.646 Millions	$ 0.035 Millions
Bespoke Extracts Inc	17.46	$ 0.786 Millions	$ 0.045 Millions
Halozyme Therapeutics Inc	17.02	$ 829.253 Millions	$ 48.721 Millions
Qhslab Inc	16.93	$ 1.409 Millions	$ 0.083 Millions

Date modified: 2026-10-07T00:41:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.